
|Articles|April 17, 2017
Identifying Circulating Exosomes as a Biomarker in Glioma
Author(s)Michael Ciesielski, PhD
In this video, Michael Ciesielski, PhD, of Roswell Park Cancer Institute in Buffalo, talks about circulating exosomes isolated from the serum of malignant glioma patients enrolled in a completed phase I clinical trial of an anti-survivin vaccine (SurVaxM).
Advertisement
Dr. Ciesielski
Newsletter
Stay up to date on recent advances in the multidisciplinary approach to cancer.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on CancerNetwork
1
Modifiable Risk Factors Suggest Potential for Improving Cancer Prevention
2
Dato-DXd Receives Priority Review in Unresectable/Metastatic TNBC
3
Exploring The Impact of ADTs on Cardiac Risk in Prostate Cancer Treatment
4
Barriers to CAR T-Cell Referral and Center Access in Multiple Myeloma
5



































